News about genomics analysis tools including next generation sequencing, electrophoresis, PCR, and others
Researchers in Switzerland no longer need to import IDT products; local expertise facilitates ordering SKOKIE, IL (May 2, 2017) – Integrated DNA Technologies (IDT), has signed a distributor agreement withLubioScience GmbH (LubioScience), based in Lucerne, Switzerland. Through LubioScience, researchers in Switzerland will benefit from local access to IDT’s full range of high quality reagents for... Read more
SAN FRANCISCO, Calif. – May 1, 2017 – Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced the appointment of Mark Daniels to the newly-created position of chief ethics and compliance officer. Mr. Daniels will maintain his current position as Twist Bioscience’s general counsel, and in his expanded role,... Read more
Investors are always looking for stocks that are poised to beat at earnings season and Becton, Dickinson and Company BDX may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report. That is because Becton is seeing favorable earnings estimate revision activity as... Read more
26 Apr, 2017, 09:00 ET SEOUL, South Korea, April 26, 2017 /PRNewswire/ — Seegene Inc. (096530.KQ), the leading developer of multiplex PCR technologies, announced that it is entering into more innovative and powerful business realm by developing the Second-generation Real-time PCR Technology which has been recently patented in the United States and Europe. Seegene’s Second-generation... Read more
FRANKLIN LAKES, N.J., Apr. 26, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has non-exclusively licensed its patented stochastic labelling technology to Roche for multiple commercial applications. BD’s patented stochastic labelling technology incorporating molecular indexes (known also as UMIs or molecular barcodes), enables the... Read more
CAMBRIDGE, UK and SAN DIEGO, USA – April 20, 2017 – Congenica and Edico Genome today announced the companies have partnered to offer their complementary platform technologies as an all-in-one, genome data analysis solution that accelerates clinical labs’ and hospitals’ progression from DNA sequencing to diagnosis for inherited diseases which otherwise takes months or years.... Read more
Company Holds Largest IP Portfolio Encompassing Processor-Based Analysis of Next-Generation Sequencing Data SAN DIEGO, March 20, 2017 – Edico Genome, creator of the world’s first processor designed to analyze next-generation sequencing data, today announced the United States Patent and Trademark Office has issued an additional five, foundational patents surrounding the DRAGEN™ platform for analysis and storage... Read more
Hamburg, April 2017 The product line sealed with the new purity grade “Eppendorf Forensic DNA Grade” complies with the stringent requirements of the recently released ISO18385. This standard specifies the demands on manufacturers of products which are used in forensic DNA laboratories to further minimize the risk of contamination. Eppendorf confirms the compliance for every... Read more
Agreement centered on next-generation sequencing oncology research and companion diagnostic development programs CARLSBAD, Calif., April 18, 2017 /PRNewswire/ — Thermo Fisher Scientific has signed an agreement with the Institute of Medical Genetics and Pathology at University Hospital Basel, Switzerland, to establish the leading institution as the first partner in the Next Generation Sequencing Companion Dx Center... Read more
Proceeds Intended to Facilitate Completion of Merger with Precipio Diagnostics During Second Quarter of 2017 OMAHA, Neb. (April 17, 2017) — Transgenomic, Inc. (OTCQB: TBIO) today reported that it has received $1.15 million in proceeds from a note bridge financing.The financing is intended to help facilitate the completion of Transgenomic’s merger with Precipio Diagnostics, LLC,... Read more